Prevalence of obesity and cardiovascular risk in the general population of a health area in Extremadura (Spain). The Hermex study;Prevalencia de obesidad y riesgo cardiovascular asociado en la población general de un área de salud de Extremadura. Estudio Hermex

Endocrinologia y Nutricion

Volumn 59, Issue 3, 2012, Pages 160-168

  Félix Redondo, Francisco J ^a   Baena Díez, José M ^b   Grau, María ^c   Tormo, María ángeles ^d   Fernández Bergés, Daniel ^e  

^a Centro de Salud Villanueva Norte   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d UNIVERSITY OF EXTREMADURA   (Spain)

^e Programa de Enfermedades Cardiovasculares   (Spain)

Author keywords

Cardiovascular disease; Epidemiology; Ischemic heart disease; Obesity; Overweight; Risk factor

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SPAIN;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; OVERWEIGHT; PREVALENCE; RISK FACTORS; SAMPLING STUDIES; SMOKING; SPAIN; WAIST CIRCUMFERENCE;

EID: 84858281137     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2012.01.005     Document Type: Article

References (29)

1. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional and global trends in body-mass index since 1980: Systematic analisys of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377:557-567.
2. Aranceta-Bartrina J., Serra-Majem L., Foz-Sala M., Moreno-Esteban B. Prevalencia de obesidad en España. Med Clin (Barc) 2005, 125:460-466. grupo colaborativo SEEDO.
3. Grau M., Elosúa R., Cabrera de León A., Guembe M.J., Baena-Diez J.M., Vega Alonso T., et al. Factores de riesgo cardiovascular en España en la primera década del siglo xxi: análisis agrupado con datos individuales de 11 estudios de base poblacional. Estudio DARIOS. Rev Esp Cardiol 2011, 64:295-304.
4. Haslam D.W., James W.P.T. Obesity. Lancet 2005, 366:1197-1209.
5. Wilson P. Overweight and obesity as determinants of cardiovascular risk. The Framingahm experience. Arch Int Med 2002, 162:1867-1872.
6. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.
7. Shulte H., Cullen P., Assmann G. Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM). Atherosclerosis 1999, 144:199-209.
8. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
9. Salas-Salvadó J., Rubio M.A., Barbany M., Moreno B. Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc) 2007, 128:184-196. SEEDO, Grupo Colaborativo.
10. Félix-Redondo F.J., Fernández-Bergés D., Pérez J.F., Zaro M.J., García A., Lozano L., et al. Prevalencia de los factores de riesgo cardiovascular en Extremadura. Estudio Hermex. Aten Primaria 2011, 43:426-434.
11. Estudio HERMEX. Metodología, resultados y conclusiones del estudio piloto 2008, Estudio de la prevalencia de los factores de riesgo cardiovascular en un área sanitaria de Badajoz, Consejería de Sanidad. Junta de Extremadura, Mérida, [consultado 25 junio 2011]. Disponible en: http://www. grimex.org/HERMEX/files/Hermex Estudio Piloto.pdf.
12. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity.
13. Marrugat J., Solanas P., D'Agostino R., Sullivan L., Ordovas J., Cordon F., et al. Estimación del riesgo coronario en España mediente la ecuación de Framingham calibrada. Rev Esp Cardiol 2003, 56:253-261.
14. Marrugat J., Vila J., Baena-Diez J.M., Grau M., Sala J., Ramos R., et al. Validez relativa de la estimación del riesgo cardiovascular a 10 años en una cohorte poblacional del estudio Regicor. Rev Esp Cardiol 2011, 64:385-394.
15. Marrugat J., Subirana I., Comin E., Cabezas C., Vila J., Elosua R., et al. Validity of a adaptation of the Framinghan cardiovascular risk function: the VERIFICA study. J Epidemiol Health 2007, 61:40-47.
16. Medrano M.J., Pastor-Barriuso R., Boix R., del Barrio J.L., Damián J., álvarez R., et al. Riesgo coronario atribuible a los factores de riesgo cardiovascular en población española. Rev Esp Cardiol 2007, 60:1260-1356.
17. Grau M., Subirana I., Elosua R., Fitó M., Covas M.I., Sala J., et al. Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe. Prev Med 2010, 51:78-84.
18. Zalesin K.C., Franklin B.A., Miller W.M., Peterson E.D., McCullough P.A. Impact of obesity on cardiovascular disease. Endocrinol Metab Clin Nort Am 2008, 27:663-684.
19. Perez A., Ybarra J., Blay V., de Pablos P. Obesity and cardiovascular disease. Public Health Nutr 2007, 10:1156-1163.
20. Nieman D.C., Henson D.A., Nehlsen-Cannarella S.L., Ekkens M., Utter A.C., Butterworth D.E., et al. Influence of obesity on immune function. J Am Diet Assoc 1999, 99:294-299.
21. Hajer G.R., van Haeften T., Visseren F.L.J. Adipose tissue dysfunction in obesity, diabetes and cardiovascular disease. Eur Heart J 2008, 29:2959-2971.
22. Van Gaal L.C., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
23. Gutierrez-Fisac J.L., Lopez E., Banegas J.R., Graciani A., Rodriguez-Artalejo F. Prevalence of overweight and obesity in elderly people in Spain. Obes Res 2004, 12:710-715.
24. Moreira M.N. ¿Que medida antropométrica de exceso de peso discrimina mejor el riesgo cardiovascular?. Med Clin (Barc) 2010, 134:396-398.
25. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries: case-control study. Lancet 2004, 364:937-952. INTERHEART study investigators.
26. Darmon N., Drewnosky A. Does social class predict diet quality?. Am J Clin Nutr 2008, 87:1107-1117.
27. Baena-Díez J.M., Félix F.J., Grau A., Cabrera de León A., Sanz H., Leal M., et al. Tratamiento y control de los factores de riesgo según el riesgo coronario en la población española del estudio DARIOS. Rev Esp Cardiol 2011, 64:766-773.
28. Estrategia NAOS. [consultado 25 junio 2011]. Disponible en: http://www.naos.aesan.msps.es/naos/estrategia/que_es/.
29. Kumanyika S.K., Obarzanek E., Stettler N., Bell R., Field A.E., Fortmann S.P., et al. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation 2008, 118:428-464. American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention.